PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medicine, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada jim.russell@hli.ubc.ca.\', \'Surgery, University of Toronto, Toronto, Ontario, Canada.\', \'Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.\', \'Paediatrics, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Emergency Medicine, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.\', \'Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Medical ICU, Peking University, Beijing, China.\', \'Medicine, Wuhan University Zhongnan Hospital, Wuhan, China.\', \'Department of Medicine, McGill University, Montreal, Quebec, Canada.\', \'Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.\', \'Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2020-040768
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33293316
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all